GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Amicogen 092040.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

963

+0.42%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩41.98bn

FY2016FY2025

Net income

−₩29.96bn

FY2016FY2025

Free cash flow

−₩28.20bn

FY2016FY2025

Shareholders' equity

₩94.57bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩41.98bn₩173.60bn₩159.90bn₩144.30bn₩124.88bn₩115.86bn₩115.18bn₩94.52bn₩73.67bn₩68.97bn
Gross profit₩5.51bn₩50.48bn₩68.39bn₩58.70bn₩55.72bn₩54.93bn₩48.50bn₩30.52bn₩24.80bn₩23.75bn
Research and development₩7.45bn₩12.61bn₩13.78bn₩12.44bn₩10.84bn₩6.28bn—₩5.18bn₩4.77bn₩2.81bn
Operating income−₩24.50bn—−₩1.00bn−₩8.80bn−₩7.75bn₩482.7m−₩189.9m₩1.44bn−₩2.06bn₩4.18bn
Net income−₩29.96bn−₩52.79bn−₩23.29bn−₩47.22bn₩3.73bn₩31.60bn₩86.7m₩40.17bn−₩4.61bn₩1.59bn
Diluted earnings per share-1,559.61-2,748.16-1,212.36-2,458.14194.311,645.244.512,091.04-239.9982.70

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩231.86bn₩294.23bn₩467.10bn₩429.65bn₩411.22bn₩283.37bn₩241.40bn₩231.21bn₩163.51bn₩146.33bn
Cash and short-term investments—₩9.04bn₩31.53bn₩23.69bn₩42.55bn₩44.01bn₩26.50bn₩14.84bn₩22.23bn₩14.26bn
Total liabilities₩136.00bn₩171.73bn₩248.12bn₩297.86bn₩225.06bn₩130.43bn₩119.35bn₩103.93bn₩74.32bn₩64.79bn
Debt₩53.69bn₩107.04bn₩139.61bn₩138.45bn₩79.40bn₩42.12bn₩38.16bn₩34.26bn₩23.34bn₩22.38bn
Shareholders' equity₩94.57bn₩122.50bn₩175.84bn₩131.80bn₩186.16bn₩152.94bn₩122.05bn₩127.28bn₩89.19bn₩81.54bn
Shares outstanding19m19m19m19m19m19m19m19m19m19m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−₩24.42bn−₩13.34bn₩8.64bn−₩22.41bn₩8.07bn₩8.87bn₩8.76bn₩2.84bn₩11.88bn₩11.28bn
Capital spending−₩3.77bn−₩49.82bn−₩62.60bn−₩45.91bn−₩47.31bn−₩13.85bn−₩19.26bn−₩10.88bn−₩11.45bn−₩16.95bn
Free cash flow−₩28.20bn−₩63.15bn−₩53.96bn−₩68.32bn−₩39.24bn−₩4.99bn−₩10.50bn−₩8.04bn₩432.5m−₩5.68bn
Dividends paid—————————−₩911.6m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩13.39bn₩12.28bn₩10.87bn₩10.14bn₩10.15bn₩10.82bn₩56.85bn₩39.90bn
Gross profit₩2.90bn₩2.62bn₩2.08bn₩556.1m₩1.38bn₩1.49bn₩14.21bn₩17.00bn
Operating income——−₩3.74bn−₩4.80bn−₩4.95bn−₩3.55bn—−₩964.4m
Net income−₩20.75bn₩19.70bn−₩5.38bn−₩12.86bn−₩6.00bn−₩5.71bn−₩38.85bn₩931.4m
Diluted earnings per share-1,080.161,025.75-280.31-669.64-312.18-297.48-2,022.6048.49
Cash from operations₩4.09bn−₩3.58bn₩1.10bn−₩2.22bn−₩42.90bn₩19.59bn−₩13.34bn−₩2.70bn
Capital spending−₩78.0m−₩39.0m−₩113.0m−₩898.0m−₩339.0m−₩2.42bn−₩49.82bn−₩45.67bn
Free cash flow₩4.01bn−₩3.62bn₩992.0m−₩3.12bn−₩43.24bn₩17.17bn−₩63.15bn−₩48.37bn
Total assets₩197.17bn₩213.68bn₩231.86bn₩240.57bn₩255.70bn₩273.84bn₩294.23bn₩481.58bn
Cash and short-term investments—————₩17.72bn₩9.04bn₩26.74bn
Debt₩30.61bn₩33.85bn₩53.69bn₩58.63bn₩62.45bn₩104.50bn₩107.04bn₩158.26bn
Shareholders' equity₩118.00bn₩132.40bn₩94.57bn₩100.83bn₩109.42bn₩116.89bn₩122.50bn₩171.10bn

Financial ratios

Data as of 9 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Gross margin13.1%29.1%42.8%40.7%44.6%47.4%———
Operating margin-58.4%—-0.6%-6.1%-6.2%0.4%-2.2%——
Net margin-71.4%-30.4%-14.6%-32.7%3.0%27.3%———
Return on equity-31.7%-43.1%-13.2%-35.8%2.0%20.7%———
Return on assets-12.9%-17.9%-5.0%-11.0%0.9%11.2%———
Free cash flow yield———————73.3%124.7%
Revenue growth-75.8%8.6%10.8%15.5%7.8%0.6%———
Earnings growth-43.2%126.7%-50.7%-1365.0%-88.2%36344.8%———
Current ratio0.47x0.89x0.89x0.70x0.76x1.56x———
Debt to equity0.57x0.87x0.79x1.05x0.42x0.27x———
Equity ratio40.8%41.6%37.6%30.7%45.3%54.0%———
Interest coverage-3.16x—-0.09x-1.18x-2.63x0.36x———
R&D as a share of sales17.7%7.3%8.6%8.6%8.7%5.4%———
Buybacks as a share of market value———————-0.1%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-33.7%-18.4%2.6%
Operating income40.7%——
Net income-14.1%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin26.0%35.2%38.6%37.8%
Net margin-38.4%-29.5%-15.5%-6.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-1.1-1.4-6.2-3.675.410.8—7.5-45.9122.9
Price to sales0.80.40.91.22.32.92.03.22.92.8

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 29 Dec 2015.

FY2016FY2015
Paid in the year22.80727.369
  • 2-for-1 split · 13 Dec 2023
  • 684-for-631 split · 23 Oct 2023
  • 2-for-1 split · 2 Apr 2018
  • 2-for-1 split · 22 Aug 2014

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.